The largest database of trusted experimental protocols

Mart 1 dextramer

Manufactured by Immudex

The MART-1 Dextramer is a lab equipment product developed by Immudex. It is a tool used for the identification and enrichment of antigen-specific T cells in biological samples. The MART-1 Dextramer is designed to bind to T cell receptors specific for the MART-1 antigen, which is commonly associated with melanoma. The product's core function is to facilitate the detection and isolation of MART-1-specific T cells for research and clinical applications.

Automatically generated - may contain errors

2 protocols using mart 1 dextramer

1

Generation of MART-1-specific CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DCs were generated by isolating CD14+ cells from PBMCs (Discovery Life Sciences Inc.) using the CD14 enrichment kit (Miltenyi) according to the manufacturer’s instructions and cultured in Dendritic Cell media (Cellgro) containing 1% human AB serum supplemented with rhIL-4 (100 ng/ml) and rhGM-CSF (100 ng/ml, Peprotech). The media was removed on day 4 of culture and replaced with fresh media containing 1% human AB serum supplemented with rhIL-4, rhGM-CSF, and hIFN-γ (10 ng/ml, Peprotech), lipopolysaccharide (10 ng/ml, MilliporeSigma), and MART-1 peptide (2.5 μg/ml, Anaspec). On day 5, the mature DCs were harvested and irradiated at 30 Gy. Naive CD8+ T cells were isolated using the Naive CD8 Isolation kit (StemCell) and cultured with irradiated DCs in media containing 5% human AB serum supplemented with rhIL-21 (30 ng/ml), MART-1 peptide, rhIL-7 (5 ng/ml), and rhIL-15 (5 ng/ml). Fresh media supplemented with rhIL-7 and rhIL-15 was added on day 3, 5, and 7. Cells were harvested on day 10 and antigen specificity was assessed by staining with MART-1 Dextramer (Immudex) and analyzing by flow cytometry.
+ Open protocol
+ Expand
2

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used for the analysis of surface and intracellular markers: anti-CD73 (2C5) antibody was discovered at AstraZeneca (18 (link)) and conjugated to fluorochrome in house; anti-CD73 (TY/11.8) was purchased from BioLegend; anti-Ki-67 (SolA15), anti-granzyme B (GB11), and anti-CD8 (OKT8) were purchased from eBioscience; and FcR blocking reagent was purchased from Miltenyi Biotec. Intranuclear staining was performed using Fixation/Permeabilization buffer solution (eBioscience) according to the manufacturer’s instructions. MART-1 dextramer was purchased from Immudex, and the staining was performed according to the manufacturer’s instructions. In some experiments, cells were treated with EGF (50 ng/ml), EGFR inhibitors (osimertinib, 1 μM, AstraZeneca), NF-κB inhibitor (IKK inhibitor VII, 1 μM, MilliporeSigma), ERK inhibitor (LY3214996, 1 μM, Selleckchem), or PKC inhibitor (Go 6983, 10 μM, MilliporeSigma) for 48 hours before analysis. Stained cells were analyzed on a LSRFortessa (BD Biosciences), and data were analyzed with FlowJo software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!